MedTrace Logo

Letrozole Pretreatment With Misoprostol Induction of Abortion in First Trimester Missed Abortion

NCT04590482 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2020-10-29

No results posted yet for this study

Summary

this study will compare the efficacy of using letrozole pre treatment before misoprostol versus using misoprostol only in the induction of first trimester missed abortion.

Conditions

  • Missed Abortion

Interventions

DRUG

letrozole

Letrozole 2.5 mg each 12 hours for 2 days followed by vaginal misoprostol 800 mcg for induction of abortion

DRUG

placebo

placebo given twice daily for 2 days followed by 800mcg misoprostol vaginally to induce abortion

Sponsors & Collaborators

  • Shereen Rady Abou El-fetouh

    lead OTHER

Principal Investigators

  • shereen khedr · AinShams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2021-03-16
Completion
2021-05-08

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590482 on ClinicalTrials.gov